Ads
related to: gene therapy for sickle cell disease- Safety and Side Effects
Review the Safety Profile
And Potential Side Effects.
- Find Treatment Centers
Find an Authorized Treatment Center
By Using the Map Search Feature.
- Mechanism of Action
See How Gene Therapy Works.
Learn the Science Behind Treatment
- Prescribing Information
View Full Prescribing Information &
Indications And Usage.
- Treatment Journey
Learn More About Treatment And
See If It's Right for Your Patients
- HCP Resources
Download Treatment Brochures,
Billing Codes, and More.
- Safety and Side Effects
Search results
Results From The WOW.Com Content Network
CEO Andrew Obenshain said the latest restructuring would help support the marketing of its three gene therapies, including the recently approved sickle cell disease treatment, Lyfgenia ...
Cystic fibrosis (also known as CF or mucoviscidosis) is an autosomal recessive genetic disorder affecting most critically the lungs, and also the pancreas, liver, and intestine.
Voxelotor has been shown to have disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators in sickle cell patients. [8] It initially appeared to have an acceptable safety profile in sickle cell patients and healthy volunteers, without any dose-limiting toxicity noted in clinical trials. [9]
Gene therapy refers to a form of treatment where a healthy gene is introduced to a patient. This should alleviate the defect caused by a faulty gene or slow the progression of the disease. A major obstacle has been the delivery of genes to the appropriate cell, tissue, and organ affected by the disorder.
Photomicrograph of normal-shaped and sickle-shape red blood cells from a patient with sickle cell disease. Sickle cell anemia is a genetic disease that causes deformed red blood cells with a rigid, crescent shape instead of the normal flexible, round shape. [29] It is caused by a change in one nucleotide, a point mutation [30] in the HBB gene.
Animal testing for gene therapy began in 2007 with a 2009 breakthrough in squirrel monkeys suggesting an imminent gene therapy in humans. While the research into gene therapy for red-green colorblindness has lagged since then, successful human trials are ongoing for achromatopsia. Congenital color vision deficiency affects upwards of 200 ...
Ads
related to: gene therapy for sickle cell disease